Ceretas Limited (ASX:CTS)

Market Cap	42.11M
Revenue (ttm)	n/a
Net Income	-275.07K
EPS	-0.01
Shares Out	71.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,028
Open	0.5950
Previous Close	0.5900
Day's Range	0.5900 - 0.5950
52-Week Range	0.2500 - 0.6200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Ceretas

Ceretas Limited engages in developing a portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company offers a device that uses focused ultrasound beams directed through the skull to interact non-invasively with brain tissue. The company’s technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the bl...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2024
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CTS

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 11, 2026

Data Sources Report a data error